The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago from May 30 to June 03 2025 is one of the most important global oncology events. During this years's ASCO, Simcere Zaiming showcased a total of 18 clinical studies regarding 5 innovative assets, including Suvemcitug, SIM0270,Trilciclib, envafolimab and endostatin.
